BetterLife Pharma (BETRF) Total Liabilities (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Total Liabilities of $4.9 million for Q2 2026, up 9.75% year-over-year from $4.4 million in Q2 2025, and up 0.8% quarter-over-quarter from $4.8 million in Q1 2026.
BetterLife Pharma (BETRF) Total Liabilities (2011 - 2026) Analysis & Trends
BetterLife Pharma's Total Liabilities history runs 16 years deep, the most recent figure standing at $4.9 million for Q2 2026.
- In Q2 2026, Total Liabilities rose 9.75% year-over-year to $4.9 million; the TTM figure through Apr 2026 stood at $4.9 million (up 9.75% YoY), while the FY2026 annual figure was $4.8 million, down 9.58% from the prior year.
- Total Liabilities for Q2 2026 stood at $4.9 million, up from $4.8 million in the prior quarter.
- The five-year high for Total Liabilities was $6.3 million in Q2 2024, with the low at $4.0 million in Q1 2022.
- The 5-year median for Total Liabilities is $5.3 million (2023), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 72.44% in 2022, then slipped 29.76% in 2025.
- BetterLife Pharma's Total Liabilities stood at $5.2 million in 2022, then gained by 2.04% to $5.3 million in 2023, then fell by 4.44% to $5.1 million in 2024, then declined by 13.2% to $4.4 million in 2025, then advanced by 10.8% to $4.9 million in 2026.
- Business Quant data shows BETRF's Total Liabilities at $4.9 million in Q2 2026, $4.8 million in Q1 2026, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 10.03 Bn |
| 10 | BetterLife Pharma | 33.62 Mn | 33.60 Mn | - | 4.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 4.87 Mn |
| Jan 31, 2026 | 4.83 Mn |
| Jul 31, 2025 | 4.40 Mn |
| Apr 30, 2025 | 4.44 Mn |
| Jan 31, 2025 | 5.34 Mn |
| Oct 31, 2024 | 5.06 Mn |
| Jul 31, 2024 | 5.86 Mn |
| Apr 30, 2024 | 6.32 Mn |
| Jan 31, 2024 | 5.93 Mn |
| Oct 31, 2023 | 5.30 Mn |
| Jul 31, 2023 | 5.52 Mn |
| Apr 30, 2023 | 5.27 Mn |
| Jan 31, 2023 | 5.64 Mn |
| Oct 31, 2022 | 5.19 Mn |
| Jul 31, 2022 | 5.46 Mn |
| Apr 30, 2022 | 5.18 Mn |
| Jan 31, 2022 | 3.98 Mn |
| Oct 31, 2021 | 3.01 Mn |
| Jul 31, 2021 | 3.59 Mn |
| Apr 30, 2021 | 4.18 Mn |